Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (5 cm).
Sun J, Zhang T, Wang J, Li W, Zhang A, He W, Zhang D, Li D, Ding J, Duan X.
BMC Cancer. 2019 Aug 28;19(1):846. doi: 10.1186/s12885-019-6063-9.
PMID:31455251
Evaluating the biologically effective dose (BED) concept using a dynamic tumor simulation model.
Dahlman EL, Watanabe Y.
Med Phys. 2020 Aug;47(8):3710-3720. doi: 10.1002/mp.14228. Epub 2020 Jun 8.
PMID:32385934
Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results.
Reyngold M, Parikh P, Crane CH.
Radiat Oncol. 2019 Jun 6;14(1):95. doi: 10.1186/s13014-019-1309-x.
PMID:31171025
Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (5 cm) with CyberKnife: protocol of study.
Sun J, Zhang A, Li W, Wang Q, Li D, Zhang D, Duan X.
Radiat Oncol. 2020 Jan 28;15(1):20. doi: 10.1186/s13014-020-1471-1.
PMID:31992327
Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.
Nieder C, Grosu AL, Andratschke NH, Molls M.
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1446-9. doi: 10.1016/j.ijrobp.2006.07.1383. Epub 2006 Nov 2.
The role of the concept of biologically effective dose (BED) in treatment planning in radiosurgery.
Millar WT, Hopewell JW, Paddick I, Lindquist C, Nordströn H, Lidberg P, Gårding J.
Phys Med. 2015 Sep;31(6):627-33. doi: 10.1016/j.ejmp.2015.04.008. Epub 2015 May 14.
PMID:25982304
Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer.
Miles EF, Nelson JW, Alkaissi AK, Das S, Clough RW, Broadwater G, Anscher MS, Chino JP, Oleson JR.
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):139-46. doi: 10.1016/j.ijrobp.2009.04.052. Epub 2009 Oct 14.